Tony Zhang

Tony Zhang is a highly experienced professional with a distinguished 25-year career in pharmaceutical research and development.

Prior to co-founding Tyligand in 2018, Tony held key positions at Eli Lilly, including Senior Research Fellow in Small Molecule Design and Development, Vice President of Global External R&D for Asia, and founding Managing Director of China R&D.

His expertise spans various areas such as pharmaceutical R&D, risk assessment, project management, CMC development, medicinal and process chemistry, formulation development, licensing, collaborations, clean technologies, green chemistry, and patient-centered pharmaceutical product and process design.

Tony Zhang holds a Doctor of Philosophy (PhD) in Chemistry from Purdue University and a Bachelor of Science (BS) in Chemistry from Shandong University.

Throughout his career, he has served in leadership roles, including CEO at Tyligand Bioscience, and played significant roles at Eli Lilly and Company, shaping the landscape of pharmaceutical research and development.

With a profound understanding of the pharmaceutical industry and a solid academic background, Tony Zhang continues to drive innovation and excellence in the field.